Trials / Suspended
SuspendedNCT01527747
Effects of DPP-4 Inhibition on Triglycerides
Effects of Dipeptidyl Peptidase-4 Inhibition With Saxagliptin on Fasting and Postprandial Triglyceride Concentrations
- Status
- Suspended
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the effects of saxagliptin, a treatment for diabetes, on fasting and post-meal blood triglyceride (blood fat) levels.
Detailed description
This study is designed to help us understand the effects of DPP-4 inhibition on triglyceride levels before and after eating.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saxagliptin | 5 mg daily |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2024-11-01
- Completion
- 2024-12-01
- First posted
- 2012-02-07
- Last updated
- 2023-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01527747. Inclusion in this directory is not an endorsement.